AIP4 Antibodies

Santa Cruz Biotechnology delivers a wide array of AIP4 monoclonal antibodies for research focused on understanding AIP4's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AIP4, also known as ARIH1, is an E3 ubiquitin ligase that plays a critical role in regulating protein degradation and cellular signaling pathways. AIP4 is involved in the modulation of various cellular processes, including cell cycle progression, apoptosis, and immune response. Understanding AIP4's function is particularly important due to its role in maintaining cellular homeostasis. Research has shown that AIP4 dysregulation can contribute to various pathological conditions. Investigating AIP4's molecular mechanisms and interactions can provide valuable insights into disease development and potential therapeutic strategies. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of AIP4's biological significance.